Optimized surface markers for the prospective isolation of high-quality hipscs using flow cytometry selection

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Abujarour, Ramzey ^a   Valamehr, Bahram ^a   Robinson, Megan ^a   Rezner, Betsy ^a   Vranceanu, Florin ^a   Flynn, Peter ^a  

^a Fate Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; HOMEODOMAIN PROTEIN; MEMBRANE ANTIGEN; NANOG PROTEIN, HUMAN; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN; STAGE SPECIFIC EMBRYO ANTIGEN 4; STAGE-SPECIFIC EMBRYONIC ANTIGEN-4; TRA 1 81 ANTIGEN, HUMAN; TRA-1-81 ANTIGEN, HUMAN;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL SEPARATION; CYTOLOGY; FLOW CYTOMETRY; GENETICS; HUMAN; KARYOTYPING; METABOLISM; MOUSE; NUCLEAR REPROGRAMMING; PATHOLOGY; PLURIPOTENT STEM CELL; TERATOMA;

ANIMALS; ANTIGENS, CD30; ANTIGENS, SURFACE; CELL DIFFERENTIATION; CELL LINE; CELL SEPARATION; FLOW CYTOMETRY; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KARYOTYPING; MICE; NUCLEAR REPROGRAMMING; OCTAMER TRANSCRIPTION FACTOR-3; STAGE-SPECIFIC EMBRYONIC ANTIGENS; TERATOMA;

MLCS; MLOWN;

EID: 84873697872     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01179     Document Type: Article

References (28)

1. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
2. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007). (Pubitemid 350138099)
3. Grskovic, M., Javaherian, A., Strulovici, B. & Daley, G. Q. Induced pluripotent stem cells-opportunities for disease modelling and drug discovery. Nat Rev Drug Discov 10, 915-929 (2011).
4. Rao, M. S. & Malik, N. Assessing iPSC reprogramming methods for their suitability in translational medicine. J Cell Biochem (2012).
5. Lowry, W. E. et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 105, 2883-2888 (2008). (Pubitemid 351723638)
6. Chan, E. M. et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 27, 1033-1037 (2009).
7. Valamehr, B., Tsutsui, H.,Ho, C. M.&Wu, H. Developing defined culture systems for human pluripotent stem cells. Regenerative medicine 6, 623-634 (2011).
8. Valamehr, B. et al. A novel platform to enable the high-throughput derivation and characterization of feeder-free human iPSCs. Sci Rep 2, 213 (2012).
9. Zhao, W., Ji, X., Zhang, F., Li, L. & Ma, L. Embryonic stem cell markers. Molecules 17, 6196-6236.
10. Schopperle, W. M. & DeWolf, W. C. The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. Stem Cells 25, 723-730 (2007). (Pubitemid 46354232)
11. Wang, Y. C. et al. Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis. Cell research 21, 1551-1563 (2011).
12. Kardel, M. D. & Eaves, C. J. Modeling human hematopoietic cell development from pluripotent stem cells. Experimental hematology 40, 601-611 (2012).
13. Drukker, M. et al. Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells. Nat Biotechnol 30, 531-542 (2012).
14. Tang, C. et al. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol 29, 829-834 (2011).
15. Yuan, S. H. et al. Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS One 6, e17540 (2011).
16. Adewumi, O. et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 25, 803-816 (2007). (Pubitemid 47052190)
17. Draper, J. S., Pigott, C., Thomson, J. A. & Andrews, P. W. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat 200, 249-258 (2002). (Pubitemid 34467317)
18. Mateizel, I. et al. Characterization of CD30 expression in human embryonic stem cell lines cultured in serum-free media and passaged mechanically. Hum Reprod 24, 2477-2489 (2009).
19. Holford, L. C., Case, P. & Lawson, S. N. Substance P, neurofilament, peripherin and SSEA4 immunocytochemistry of human dorsal root ganglion neurons obtained from post-mortem tissue: a quantitative morphometric analysis. Journal of neurocytology 23, 577-589 (1994). (Pubitemid 24283946)
20. Piao, J. H. et al. Cellular composition of long-term human spinal cord-and forebrain-derived neurosphere cultures. Journal of neuroscience research 84, 471-482 (2006).
21. Barraud, P., Stott, S., Mollgard, K., Parmar, M. & Bjorklund, A. In vitro characterization of a human neural progenitor cell coexpressing SSEA4 and CD133. Journal of neuroscience research 85, 250-259 (2007). (Pubitemid 46219293)
22. Kershaw, D. B. et al. Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin. The Journal of biological chemistry 272, 15708-15714 (1997). (Pubitemid 27265543)
23. Nielsen, J. S. & McNagny, K. M. The role of podocalyxin in health and disease. Journal of the American Society of Nephrology : JASN 20, 1669-1676 (2009).
24. Kurts, C. et al. Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells. Nature 398, 341-344 (1999).
25. Deutsch, Y. E., Tadmor, T., Podack, E. R. & Rosenblatt, J. D. CD30: an important new target in hematologic malignancies. Leukemia & lymphoma 52, 1641-1654 (2011).
26. Rosler, E. S. et al. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev Dyn 229, 259-274 (2004). (Pubitemid 38140465)
27. Viswanathan, S. R. et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 41, 843-848 (2009).
28. Saha, K. & Jaenisch, R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 5, 584-595 (2009).